Alaunos Therapeutics | ZIOP - Assets


Alaunos Therapeutics reported $3.72M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Amgen USD 90.59B 445M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Biogen USD 29.44B 232M Dec/2025
Bioline Rx USD 39.8M 3.47M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Celltrion KRW 21.08T 530.63B Sep/2025
Corcept Therapeutics USD 836.65M 13.04M Dec/2025
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Curis USD 19.97M 9.27M Dec/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Incyte USD 6.96B 627.62M Dec/2025
Intrexon USD 73.16M 77.88M Jun/2024
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Karyopharm Therapeutics USD 108.42M 12.18M Dec/2025
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Organigram Holdings CAD 530.67M 31.54M Dec/2025
Ovoca Bio EUR 1.66M 9.75M Jun/2025
Pfizer USD 208.73B 2.64B Sep/2025
Pharma Mar EUR 395.08M 53.42M Dec/2025
PTC Therapeutics USD 2.9B 255.07M Dec/2025
Qiagen NV USD 6.3B 257.54M Dec/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sartorius EUR 9.61B 413.4M Sep/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
TG Therapeutics USD 1.06B 38.23M Dec/2025
Tilray USD 2.1B 15.95M Sep/2025
Verastem USD 246.44M 69.59M Dec/2025
Zealand Pharma A/S 15.95B 848.45M Dec/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025